Company Profile
PerkinElmer Stock Price, News & Catalysts
- Ticker:
- RVTY
- Exchange:
- NYSE
- Sector:
- MedTech
- Location:
- United States
Stock performance
149.06 USD (-2.51%)
Close
Last updated: October 1, 2026
11.2B USD
Market cap
Why the stock is moving
As of Oct 1, 2026, RVTY closed down 2.51% at $149.06. No new same-company headline was identified in the current news window.
Company overview
Health Science Tools and Diagnostics Company
Revvity provides technologies and services that support workflows from biological discovery through development and clinical diagnosis. Its customer base includes pharmaceutical and biotechnology companies, diagnostic laboratories, academic institutions, and government organizations.
Life Sciences Research Tools
The company offers imaging, detection, screening, automation, reagents, and assay technologies used in drug discovery and translational research. These tools help researchers study cells, proteins, genes, and disease mechanisms at multiple scales.
Translational Multi-Omics
Revvity's multi-omics capabilities combine genomic, transcriptomic, proteomic, and cellular analysis. The portfolio supports biomarker identification, target validation, and patient stratification across research and therapeutic-development workflows.
Diagnostics Portfolio
The diagnostics business supplies technologies for reproductive health, newborn screening, infectious disease, autoimmune testing, and other clinical applications. Instruments, assays, and laboratory software create recurring demand from regulated testing workflows.
Informatics and Workflow Integration
Revvity integrates laboratory informatics, data management, and analytics with its instruments and assays. This approach is intended to connect experimental data, automate interpretation, and improve continuity from discovery research to clinical use.
Future catalysts
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of PerkinElmer (RVTY)?
PerkinElmer (RVTY) most recently closed at 149.06 USD, a -2.51% move versus the previous session.
What is the market cap of PerkinElmer (RVTY)?
PerkinElmer currently has a market capitalization of 11.2B USD on BioPharmSignal.
What does PerkinElmer do?
Health Science Tools and Diagnostics Company Revvity provides technologies and services that support workflows from biological discovery through development and clinical diagnosis. Its customer base includes pharmaceutical and biotechnology companies, diagnostic laboratories, academic institutions, and government organizations. Life Sciences Research...
On which exchange is RVTY stock listed?
PerkinElmer (RVTY) is associated with NYSE, United States, MedTech.
What is Health?
Health Science Tools and Diagnostics Company Revvity provides technologies and services that support workflows from biological discovery through development and clinical diagnosis.
Which conditions is PerkinElmer targeting with Health?
Health Science Tools and Diagnostics Company Revvity provides technologies and services that support workflows from biological discovery through development and clinical diagnosis. Its customer base includes pharmaceutical and biotechnology companies, diagnostic laboratories, academic institutions, and government organizations. Life Sciences Research...
What is Science?
Health Science Tools and Diagnostics Company Revvity provides technologies and services that support workflows from biological discovery through development and clinical diagnosis.
What is Tools?
Health Science Tools and Diagnostics Company Revvity provides technologies and services that support workflows from biological discovery through development and clinical diagnosis.